Join
Live feed
·
NEWSReleasevia Quantisnow
Renalytix plc logo

Renalytix shares are trading higher after the company announced a collaboration with the Steno Diabetes Center, Copenhagen, to advance translation of precision medicine solutions for patients with Diabetes and Chronic Kidney Disease.

ByQuantisnow·Wall Street's wire, on your screen.
RNLX· Renalytix plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RNLX (Renalytix plc) and more on Quantisnow.